Paper38807603
Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease.
Wang X and 3 others. Front Immunol, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease. Papers, record 38807603. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38807603
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| Neurofilament Proteins | Major topic |
| Myelin-Oligodendrocyte Glycoprotein | Major topic |
| RNA, Messenger | Major topic |
| ErbB Receptors | Major topic |
| Severity of Illness Index | Major topic |
| Phenotype | Major topic |
| Humans | |
| Male | |
| Female | |
| Child | |
| Cross-Sectional Studies | |
| Child, Preschool | |
| Immunoglobulin G | |
| Adolescent | |
| Autoantibodies |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33601213 | NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders. | Mult Scler Relat Disord | 2021 | https://conductscience.org/library/papers/33601213 | PubMed |
| 2 | 37184659 | Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis. | J Neurol | 2023 | https://conductscience.org/library/papers/37184659 | PubMed |
| 3 | 27671902 | Neurodegeneration in multiple sclerosis and neuromyelitis optica. | J Neurol Neurosurg Psychiatry | 2017 | https://conductscience.org/library/papers/27671902 | PubMed |
| 4 | 30737333 | Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. | Neurology | 2019 | https://conductscience.org/library/papers/30737333 | PubMed |
| 5 | 33151415 | Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview. | Cell Mol Neurobiol | 2022 | https://conductscience.org/library/papers/33151415 | PubMed |
| 6 | 29875186 | CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications. | J Neurol Neurosurg Psychiatry | 2018 | https://conductscience.org/library/papers/29875186 | PubMed |
| 7 | 32434867 | Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis. | Neurology | 2020 | https://conductscience.org/library/papers/32434867 | PubMed |
| 8 | 33374173 | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33374173 | PubMed |
| 9 | 33009641 | APP Binds to the EGFR Ligands HB-EGF and EGF, Acting Synergistically with EGF to Promote ERK Signaling and Neuritogenesis. | Mol Neurobiol | 2021 | https://conductscience.org/library/papers/33009641 | PubMed |
| 10 | 24991953 | Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. | Neuron | 2014 | https://conductscience.org/library/papers/24991953 | PubMed |
| 11 | 33796113 | Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies. | Front Immunol | 2021 | https://conductscience.org/library/papers/33796113 | PubMed |
| 12 | 34517190 | High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics. | Mult Scler Relat Disord | 2021 | https://conductscience.org/library/papers/34517190 | PubMed |
| 13 | 26283909 | Myelin damage and repair in pathologic CNS: challenges and prospects. | Front Mol Neurosci | 2015 | https://conductscience.org/library/papers/26283909 | PubMed |
| 14 | 35063909 | Clinical analysis of myelin oligodendrocyte glycoprotein antibody-associated demyelination in children: A single-center cohort study in China. | Mult Scler Relat Disord | 2022 | https://conductscience.org/library/papers/35063909 | PubMed |
| 15 | 32184342 | Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease. | Neurol Neuroimmunol Neuroinflamm | 2020 | https://conductscience.org/library/papers/32184342 | PubMed |
| 16 | 15149844 | Epidermal growth factor promotes oligodendrocyte process formation and regrowth after injury. | Exp Cell Res | 2004 | https://conductscience.org/library/papers/15149844 | PubMed |
| 17 | 33290962 | Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome. | Int Immunopharmacol | 2021 | https://conductscience.org/library/papers/33290962 | PubMed |
| 18 | 30606476 | Interleukin 4 inhibits high mobility group box-1 protein-mediated NLRP3 inflammasome formation by activating peroxisome proliferator-activated receptor-γ in astrocytes. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/30606476 | PubMed |
| 19 | 25239885 | Relationships between cobalamin, epidermal growth factor, and normal prions in the myelin maintenance of central nervous system. | Int J Biochem Cell Biol | 2014 | https://conductscience.org/library/papers/25239885 | PubMed |
| 20 | 35142667 | Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer's disease. | Neural Regen Res | 2022 | https://conductscience.org/library/papers/35142667 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42602431 | Biomarkers for myelin oligodendrocyte glycoprotein-associated disease: recent advances and future. | Front Immunol | 2026 | https://conductscience.org/library/papers/42602431 | PubMed |
| 41155859 | Plasma NfL and GFAP as Candidate Biomarkers of Disease Activity in NMOSD and MOGAD. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41155859 | PubMed |
| 41153632 | MOGAD: A Shifting Landscape-From Pathogenesis to Personalised Management, Global Perspectives and Latin American Insights. | Biomedicines | 2025 | https://conductscience.org/library/papers/41153632 | PubMed |
| 40547008 | Biomarkers for diagnosis and prognosis of myelin oligodendrocyte glycoprotein antibody-associated disease - review article. | Front Immunol | 2025 | https://conductscience.org/library/papers/40547008 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| MOG | 4340 | PubTator's text mining | https://conductscience.org/library/genes/4340 | NCBI Gene |
| NEFL | 4747 | PubTator's text mining | https://conductscience.org/library/genes/4747 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38807603
GET https://conductscience.org/api/papers/v1/38807603/references?page=2